Monday, August 31, 2026
ExploreSearch
Via News
MarketstockPre-market

Less Than Two Hours Before The NASDAQ Open, IShares Is Up By 4%

ViaNews Editorial Team

November 17, 2023

Less Than Two Hours Before The NASDAQ Open, IShares Is Up By 4%

(VIANEWS) - The NASDAQ opens tomorrow, in less than two hours, and today's iShares (NASDAQ: PFF)'s post-market value is already 4.33% up.

The last session, NASDAQ finished with iShares (PFF) jumping 0.18% to $30.12. NASDAQ rose 0.07% to $14,113.67, after three consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session.

About iShares

Earnings Per Share

As for profitability, iShares has a trailing twelve months EPS of $7.01.

PE Ratio

iShares has a trailing twelve months price to earnings ratio of 3.73. Meaning, the purchaser of the share is investing $3.73 for every dollar of annual earnings.

Volume

Today's last reported volume for iShares is 3396823 which is 64.48% below its average volume of 4142260.

More news about iShares (PFF).

Categories

MarketstockPre-market

Tags

Stock MarketStockWall StreetStock PriceStock Market NowNASDAQMarket SessionIXICThe Nasdaq Stock MarketStock Price UpPremarketPrice UpiSharesPFFPremarket Nowintelligent
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com